H.I.G. Capital's C$1.3 Billion Acquisition of Converge: A New Era in IT Services
February 7, 2025 - 11:50
In a significant move within the tech industry, H.I.G. Capital has announced its acquisition of Converge for C$5.50 per share, marking a 56% premium. This strategic buyout is set to merge Converge with Mainline, forming a formidable player in the IT solutions sector. The merger is expected to enhance service offerings and expand market reach, positioning the new entity as a leader in technology services.
As the deal progresses, both companies are gearing up for a robust Q4, with strong results anticipated. The integration of resources and expertise from both firms is projected to create synergies that will drive innovation and improve customer service. The completion of this merger is slated for the second quarter of 2025, promising exciting developments for stakeholders and clients alike. This acquisition not only reshapes the competitive landscape but also underscores the growing trend of consolidation in the IT services market.
MORE NEWS
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...